跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DIAZEPAM INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DIAZEPAM INJECTION USP
Authorized
STANDARD
DIAZEPAM INJECTION USP
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
201a68ad9b29648e
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
201a68ad9b29648e
Drug Approval Canada Name
DIAZEPAM INJECTION USP
Product Name
DIAZEPAM INJECTION USP
Status
Dormant
Status Date
2022-06-10
Original Market Date
2017-03-16
Din
02385392
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous , Intramuscular
Schedule
Targeted (CDSA IV)
Ahfs
28:24.08
Atc Original
N05BA01 DIAZEPAM
Atc Name
n 05 ba 01
Aig Number
0103614001
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
DIAZEPAM
5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
201a68ad9b29648e
Type
Standard
Back to Health Canada Approvals